Life Sciences

Create Health Ventures will focus on funding early-stage digital health companies led by founders with healthcare backgrounds.

ReviR Therapeutics secures $30 million for its drug discovery platform. RetiSpec raises $10 million for its eye-diagnostics offering. SoundHealth scores $7 million for its acoustics medical device for nasal congestion.

Scopio Labs secured $42 million in Series D funding, and robotics company NAVIGANTIS closed a $12 million Series A round.

The platform includes language support, call-to-text functionality, a high degree of automation and community outreach features.

Duke-NUS Medical School's LIVE Ventures will bring together scientists and public and private sector entities to commercialize academic research concepts.

Also, a Hong Kong project has received $5 million in funding to develop LLM-run companion robots for the mentally underserved.

The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.

The funding will be used to secure FDA clearance for its benchtop blood-testing system for use in doctor's offices, clinics and pharmacies.

The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.

Antidote will use SEQSTER's operating system to improve clinical trial time lines and enhance patient engagement for pharma and life sciences companies.